I have shared my thoughts on diversity, equity, inclusion and social justice in the U.S. regarding racial distribution in ophthalmology in three prior Lindstrom’s Perspectives.
The interested reader can look them up (Jan. 25, 2021, May 25, 2022, and Dec. 25, 2023). Prior issues discussed were the racial distribution of practicing ophthalmologists, leaders in ophthalmology and patients in live surgery educational events. Today’s topic focuses on the racial distribution of patients in U.S. clinical trials. Again, there is clearly an imbalance between the U.S. population demographics